Nutrition & DietGLP-1 Drugs Cut Addiction Risk and Overdose Deaths Across Six Substances
A landmark study of over 600,000 U.S. veterans found that GLP-1 medications like semaglutide (Ozempic, Wegovy) significantly reduce the risk of developing addiction and cut overdose deaths among those already struggling. Compared to other diabetes drugs, GLP-1 users were 14% less likely to develop any substance use disorder, with standout reductions for opioids (25%), cocaine (20%), nicotine (20%), and alcohol (18%). Among veterans already diagnosed with addiction, GLP-1 use was linked to fewer hospitalizations, emergency visits, and drug-related deaths. The findings, published in The BMJ, suggest these medications may quiet reward-seeking brain pathways that drive cravings across multiple substances — extending their health benefits well beyond weight loss and diabetes management.
